GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Junshi Biosciences Co Ltd (FRA:8SJ) » Definitions » Gross-Profit-to-Asset %

Shanghai Junshi Biosciences Co (FRA:8SJ) Gross-Profit-to-Asset % : 10.52% (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Shanghai Junshi Biosciences Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Shanghai Junshi Biosciences Co's annualized Gross Profit for the quarter that ended in Jun. 2024 was €154.97 Mil. Shanghai Junshi Biosciences Co's average Total Assets over the quarter that ended in Jun. 2024 was €1,472.88 Mil. Therefore, Shanghai Junshi Biosciences Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2024 was 10.52%.


Shanghai Junshi Biosciences Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Shanghai Junshi Biosciences Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Junshi Biosciences Co Gross-Profit-to-Asset % Chart

Shanghai Junshi Biosciences Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial 15.81 19.52 30.24 7.75 6.78

Shanghai Junshi Biosciences Co Quarterly Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Mar23 Jun23 Dec23 Mar24 Jun24 Sep24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.17 - 9.30 10.52 -28.40

Competitive Comparison of Shanghai Junshi Biosciences Co's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Shanghai Junshi Biosciences Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Junshi Biosciences Co's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Junshi Biosciences Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Shanghai Junshi Biosciences Co's Gross-Profit-to-Asset % falls into.



Shanghai Junshi Biosciences Co Gross-Profit-to-Asset % Calculation

Shanghai Junshi Biosciences Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=107.271/( (1702.887+1459.256)/ 2 )
=107.271/1581.0715
=6.78 %

Shanghai Junshi Biosciences Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Jun. 2024 )/( (Total Assets (Q: Mar. 2024 )+Total Assets (Q: Jun. 2024 ))/ count )
=154.968/( (1536.142+1409.613)/ 2 )
=154.968/1472.8775
=10.52 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Jun. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Shanghai Junshi Biosciences Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Shanghai Junshi Biosciences Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Junshi Biosciences Co Business Description

Traded in Other Exchanges
Address
Nos. 36 and 58, Hai Qu Road, Room 1003, Level 10, Building 2, Pilot Free Trade Zone, Shanghai, CHN
Shanghai Junshi Biosciences Co Ltd is a China-based biotechnology companyy with all-round capabilities in innovative drug discovery and development, clinical research on a global scale, large-scale production capacity to commercialization on the full industry chain. Aiming to develop first-in-class or bestin-class drugs by way of original innovation and co-development. Companies operations are located in the PRC and the USA.

Shanghai Junshi Biosciences Co Headlines

No Headlines